Inborn Renal Aminoaciduria Overview

Save information for later
Sign Up

Learn About Inborn Renal Aminoaciduria

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Inborn Renal Aminoaciduria Local Doctors?
Elite in Inborn Renal Aminoaciduria
Elite in Inborn Renal Aminoaciduria

New York University

111 Broadway, 
New York, NY 
Languages Spoken:
English
Offers Telehealth

David Goldfarb is a Nephrologist in New York, New York. Dr. Goldfarb is rated as an Elite provider by MediFind in the treatment of Inborn Renal Aminoaciduria. His top areas of expertise are Kidney Stones, Inborn Renal Aminoaciduria, Primary Hyperoxaluria, Kidney Transplant, and Ureteroscopy.

Distinguished in Inborn Renal Aminoaciduria
Distinguished in Inborn Renal Aminoaciduria
Helsinki, FI 

Vineta Fellman practices in Helsinki, Finland. Ms. Fellman is rated as a Distinguished expert by MediFind in the treatment of Inborn Renal Aminoaciduria. Her top areas of expertise are Coenzyme Q Cytochrome C Reductase Deficiency, Gracile Syndrome, Inborn Renal Aminoaciduria, and Premature Infant.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Inborn Renal Aminoaciduria
Distinguished in Inborn Renal Aminoaciduria
Medicon Village, 
Lund, M, SE 

Eskil Elmer practices in Lund, Sweden. Mr. Elmer is rated as a Distinguished expert by MediFind in the treatment of Inborn Renal Aminoaciduria. His top areas of expertise are Gracile Syndrome, Inborn Renal Aminoaciduria, Hemosiderosis, Coronary Artery Bypass Graft (CABG), and Heart Bypass Surgery.

What are the latest Inborn Renal Aminoaciduria Clinical Trials?
Rare Kidney Stone Consortium Biobank, Rare Diseases Clinical Research Network

Summary: This study is being done to obtain samples from patients with primary hyperoxaluria, cystinuria, adenine phosphoribosyl transferase (APRT) deficiency, and Dent disease, and from their family members, for use in future research.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Characterization of Monogenic Kidney Stone Diseases

Summary: This study will attempt to identify the specific gene (coded in the DNA) and changes (mutations) within that gene that are the cause of monogenic kidney stone disease. This study will help researchers determine the characteristics of the stone disease associated with specific genes and mutations. This information may help develop more effective treatments for monogenic kidney stone diseases.